Circulating cytomegalic endothelial cells are associated with high human cytomegalovirus (HCMV) load in AIDS patients with late-stage disseminated HCMV disease

Journal of Medical Virology

Volumn 55, Issue 1, 1998, Pages 64-74

  Gerna, Giuseppe ^a   Zavattoni, Maurizio ^a   Baldanti, Fausto ^a   Furione, Milena ^a   Chezzi, Lucia ^a   Revello, M Grazia ^a,b   Percivalle, Elena ^a  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

Author keywords

Antiviral treatment; HCMV drug resistant strains; HCMV end organ disease; HCMV leukoDNAemia; HCMV viremia; Pp65 antigenemia

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CYTOMEGALOVIRUS INFECTION; DIAGNOSTIC VALUE; ENDOTHELIUM CELL; HUMAN; HUMAN CYTOMEGALOVIRUS; MAJOR CLINICAL STUDY; VIRUS CELL INTERACTION; VIRUS LOAD;

CYTOMEGALOVIRUS; DNA VIRUSES; HUMAN HERPESVIRUS 5;

EID: 0031859902     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1096-9071(199805)55:1<64::aid-jmv11>3.0.co;2-%23     Document Type: Article

References (20)

1. Baldanti F, Sarasini A, Silini E, Barbi M, Lazzarin A, Biron KK, Gerna G (1995): Four dually resistant human cytomegalovirus strains from AIDS patients: single mutations in UL97 and UL54 open reading frames are responsible for ganciclovir-and foscarnet-specific resistance, respectively. Scandinavian Journal of Infectious Diseases Suppl 99:103-104.
2. Baldanti F, Underwood M, Stanat SC, Biron KK, Chou S, Sarasini A, Silini E, Gernd G (1996): Single amino acid changes in the DNA polymerase confer foscarnet resistance and slow-growth phenotype, while mutations in the UL97-encoded phosphotransferase confer ganciclovir resistance in three double-resistant human cytomegalovirus strains recovered from patients with AIDS. Journal of Virology 70:1390-1395.
3. Boom R, Sol CJA, Salimans MMM, Jansen CL, Wertheim-Van Dillen PME, Van Der Noordaa J (1990): Rapid and simple method for purification of nucleic acids. Journal of Clinical Microbiology 28: 495-503.
4. Gerna G, Revello MG, Percivalle E, Zavattoni M, Parea M, Battaglia M (1990): Quantification of human cytomegalovirus viremia by using monoclonal antibodies to different viral proteins. Journal of Clinical Microbiology 28:2681-2688.
5. Gerna G, Baldanti F, Zavattoni M, Sarasini A, Percivalle E, Revello MG (1992a): Monitoring of ganciclovir sensitivity of multiple human cytomegalovirus strains coinfecting blood of an AIDS patient by an immediate-early antigen plaque assay. Antiviral Research 19:333-345.
6. Gerna G, Revello MG, Percivalle E, Morini F (1992b): Comparison of different immunostaining techniques and monoclonal antibodies to the lower matrix phosphoprotein (pp65) for optimal quantitation of human cytomegalovirus antigenemia. Journal of Clinical Microbiology 30:1232-1237.
7. Gerna G, Percivalle E, Revello MG, Morini F (1993): Correlation of quantitative human cytomegalovirus pp65-, p72-and p150-antigenemia, viremia and circulating endothelial giant cells with clinical symptoms and antiviral treatment in immunocompromised patients. Clinical and Diagnostic Virology 1:47-59.
8. Gerna G, Baldanti F, Sarasini A, Furione M, Percivalle E, Revello MG, Zipeto D, Zella D, the Italian Foscarnet Study Group (1994a): Effect of foscarnet induction treatment on quantitation of human cytomegalovirus (HCMV) DNA in peripheral blood polymorphonuclear leukocytes and aqueous humor of AIDS patients with HCMV retinitis. Antimicrobial Agents Chemotherapy 38:38-44.
9. Gerna G, Furione M, Baldanti F, Sarasini A (1994b): Comparative quantitation of human cytomegalovirus DNA in blood leukocytes and plasma of transplant and AIDS patients. Journal of Clinical Microbiology 32:2709-2717.
10. Gerna G, Sarasini A, Percivalle E, Zavattoni M, Baldanti F, Revello MG (1995): Rapid screening for resistance to ganciclovir and foscarnet of primary isolates of human cytomegalovirus from culture-positive blood samples. Journal of Clinical Microbiology 33:738-741.
11. Gerna G, Sarasini A, Baldanti F, Percivalle E, Zella D, Revello MG, the Italian Foscarnet GID Study Group (1997) Quantitative systemic and local evaluation of the antiviral effect of ganciclovir and foscarnet induction treatment on human cytomegalovirus gastrointestinal disease of patients with AIDS. Antiviral Research 34: 39-50.
12. Goodgame RW (1993): Gastrointestinal cytomegalovirus disease. Annals of Internal Medicine 119:924-935.
13. Grefte A, van der Giessen M, Van Son W, The TH (1993): Circulating cytomegalovirus (CMV)-infected endothelial cells in patients with an active CMV infection. Journal of Infectious Diseases 167:270-277.
14. Ljungman P, Plotkin SA (1995): Workshop on CMV disease; definitions, clinical severity scores, and new syndromes. Scandinavian Journal of Infection Diseases suppl 99; 87-89.
15. Myerson D, Hackman RC, Nelson JA, Ward DC, Mc Dougall JK (1984): Widespread presence of histologically occult cytomegalovirus. Human Pathology 15:430-439.
16. Percivalle E, Revello MG, Vago L, Morini F, Gerna G (1993): Circulating endothelial giant cells permissive for human cytomegalovirus (HCMV) are detected in disseminated HCMV infection with organ involvement. Journal of Clinical Investigation 92:663-670.
17. Revello MG, Baldanti F, Furione M, Sarasini A, Percivalle E, Zavattoni M, Gerna G (1995): Polymerase chain reaction for prenatal diagnosis of congenital human cytomegalovirus infection. Journal of Medical Virology 47:462-466.
18. Roberts WH, Sneddon JM, Waldman J, Stephens RE (1989) Cytomegalovirus infection of gastrointestinal endothelium demonstrated by simultaneous nucleic acid hybridization and immunohistochemistry. Archives of Pathology and Laboratory Medicine 113: 461-464.
19. Sarasini A, Baldanti F, Furione M, Percivalle E, Brerra R, Barbi M, Gerna G (1995): Double resistance to ganciclovir and foscarnet of human cytomegalovirus strains in three AIDS patients. Journal of Medical Virology 47:237-244.
20. Zipeto D, Baldanti F, Zella D, Furione M, Cavicchini A, Milanesi G, Gerna G (1993): Quantification of human cytomegalovirus DNA in peripheral blood polymorphonuclear leukocytes of immunocompromised patients by the polymerase chain reaction. Journal of Virological Methods 44:45-56.